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Abstract
T cells specific for persistent pathogens accumulate with age and express markers of immune senescence. In contrast, much
less is known about the state of T cell memory for acutely infecting pathogens. Here we examined T cell responses to
influenza in human peripheral blood mononuclear cells from older (.64) and younger (,40) donors using whole virus
restimulation with influenza A (A/PR8/34) ex vivo. Although most donors had pre-existing influenza reactive T cells as
measured by IFNc production, older donors had smaller populations of influenza-responsive T cells than young controls and
had lost a significant proportion of their CD45RA-negative functional memory population. Despite this apparent
dysfunction in a proportion of the older T cells, both old and young donors’ T cells from 2008 could respond to A/California/
07/2009 ex vivo. For HLA-A2+ donors, MHC tetramer staining showed that a higher proportion of influenza-specific memory
CD8 T cells from the 65+ group co-express the markers killer cell lectin-like receptor G1 (KLRG1) and CD57 compared to their
younger counterparts. These markers have previously been associated with a late differentiation state or immune
senescence. Thus, memory CD8 T cells to an acutely infecting pathogen show signs of advanced differentiation and
functional deterioration with age. There was a significant negative correlation between the frequency of KLRG1
+CD57
+
influenza M1-specific CD8 T cells pre-vaccination and the ability to make antibodies in response to vaccination with seasonal




analyzed. These results suggest that the state of the influenza-specific memory CD8 T cells may be a predictive indicator of a
vaccine responsive healthy immune system in old age.
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Introduction
The aging human immune system is characterized by a variety
of functional changes. In particular, the T cell population
undergoes dramatic alterations in old age. Thymic involution
results in a greatly diminished capacity to produce new naı ¨ve T
cells [1,2]. Exposure to common viruses such as human
cytomegalovirus (CMV) and to a lesser extent Epstein-Barr virus
(EBV), which are unable to be cleared by the immune system, can
result in the accumulation of oligoclonal T cell expansions [3–8].
The human immune system must balance control of chronic viral
infection and over-activation of pathogenic inflammatory process-
es [9]. In chronically infected hosts, the increased competition for
both space and resources in the T cell compartment leads to fewer
CD8 T cells which are able to respond to other antigens. The
combined decrease in naı ¨ve T cell output and repertoire as well as
enhanced expansion of select memory/effector T cell clones can
greatly reduce the ability to mount responses against new
pathogens. According to a longitudinal study of over one hundred
older people, approximately 9/10 elderly individuals are estimated
to be CMV-infected; the immune risk phenotype associated with
CMV expansions is a predictor of mortality in older individuals
[4]. Although some of the above alterations have been used to
predict poor outcome, we still know relatively little about what
constitutes a ‘‘healthy’’ immune system as we age [10].
Chronically stimulated T cells lose their functional capacity over
time, with upregulation of inhibitory receptors and decreased
cytolytic function [9,11,12]. Expression of killer cell lectin-like
receptor G1 (KLRG1), a proposed marker of proliferative
senescence, is increased on both mouse and human T cells
following chronic antigenic stimulation as well as on CMV-specific
CD8 T cell clones [13–15]. Moreover, co-expression of KLRG1
with another inhibitory receptor, CD57, more clearly defines the
population of CD8 T cells which are capable of producing
cytokines but unable to proliferate upon activation [16]. On the
other hand, CD8 T cells from healthy adults that are specific for
an acutely infecting pathogen, influenza, do not express significant
levels of KLRG1 [15]. Although memory T cells from chronic
infections have been extensively studied in humans, little is known
about the effect of age on the phenotype of memory T cells against
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to mount a protective response.
Influenza represents a significant disease burden in the elderly
population. Individuals 65 and over account for the majority
(almost 90%) of influenza and influenza-related pneumonia deaths
[17]. An estimated 1.4 to 16.7 deaths per 100 000 people occur
annually due to influenza infections or related complications in the
United States [17]. Influenza is a single-stranded RNA virus that
infects lung epithelial cells; binding is mediated through influenza
surface hemagglutinin (HA) protein. The seasonal influenza
trivalent inactivated vaccine (TIV) primarily elicits an antibody
response targeted against the globular head of HA. Although
neutralizing antibodies generated against HA can protect from
infection with a specific strain, these antibody responses are
generally not cross-reactive with other influenza strains [18].
However, cross-strain protection can occur from the generation of
memory T cells [18,19], as T cell epitopes are often found in
internal proteins, such as matrix protein 1, nucleoprotein, and the
PB subunit of influenza polymerase which are less susceptible to
mutation and are widely conserved between influenza strains [20–
22]. For this reason, CD8 T cells are considered critical for the
control of influenza infection, particularly in the absence of
sufficient titers of neutralizing antibodies [18,23]. Due to the
seasonal nature of influenza incidence, individuals may be acutely
infected multiple times over the course of their lifetime with a
variety of influenza A strains, primarily of the H3N2 and H1N1
subtypes. This presents a unique opportunity to examine a
repeatedly boosted T cell response to an acute viral infection in the
human population.
A number of studies have attempted to identify correlates of
protection to distinguish individuals who are at greater risk of
acquiring a severe influenza infection. Studies have confirmed that
antibody titers and T cell responses post-vaccination with TIV do
not correlate with one another [24,25]. Although some literature
has suggested that the cell-mediated compartment is less functional
in older donors, these studies were done on bulk peripheral blood
mononuclear cells (PBMC) and did not definitively identify a T
cell population responsible for producing the protective or
detrimental factors [25,26]. To address this issue, a cohort of
healthy young and older donors was recruited to examine the state
of their cross-reactive influenza-specific memory T cells. The
results show that resting, unstimulated influenza-specific memory
T cells from older donors are more differentiated than their
younger counterparts. Moreover, a more functional influenza-
specific CD8 T cell population and a lower frequency of
KLRG1
hiCD57
hi influenza M1-specific CD8 cells predict a
stronger antibody response to subsequent immunization with the
trivalent influenza vaccine (TIV). Interestingly, T cells from both
young and older donors recruited in 2008 not only responded to
influenza A/PR8 but showed similar levels of reactivity to the A/
2009 H1N1 strain, suggesting that the residual functional T cells in
the older population may well be capable of providing protection
to influenza strains sharing the conserved T cell epitopes.
Materials and methods
Ethics statement
All donors gave written informed consent and ethics approval
was granted by both institutions involved in the study, including
the Clinical Research Ethics Board of the University of British
Columbia, approved protocol H07-02008-A009 and the Research
Ethics Board of the University of Toronto, approved protocol
number 22752.
Study design and sample collection
Forty-four older donors (28 donors aged 65–74, 16 donors aged
75+) and 12 young controls (aged 20–40) were recruited at the
Vancouver Coastal Health Research Institute (Vancouver, B.C.)
prior to the 2008–2009 influenza season. Donors were vaccinated
with a standard dose of the 2008–2009 Sanofi Pasteur VaxigripH
seasonal TIV. Peripheral blood was collected pre-vaccination and
4, 10, and 20 weeks post-vaccination. PBMC were isolated by
Ficoll density gradient centrifugation and stored at 2150uC prior
to use. None of the donors recruited for this study had a confirmed
influenza infection during the 2008/2009 season. Identification of
HLA-A2 positive donors was performed by flow cytometry on
PBMC with an HLA-A2-specific labeled antibody (clone BB7.2).
Viruses and media
Stocks of influenza A/Puerto Rico/8/34 (PR8) were generated
by propagation in embryonated chicken eggs. Influenza A/
California/7/2009-like virus was produced using an MDCK cell
line system and was kindly provided by Dr. Jonathan Gubbay at
the Public Health Ontario Laboratory in Toronto. Lymphocytic
choriomeningitis virus (LCMV) Armstrong strain was kindly
provided by Dr. Pamela S. Ohashi, University Health Network,
Toronto, and propagated in the baby hamster kidney (BHK-21)
cell line (American type culture collection line CCL10). Complete
PBMC medium used for this study consisted of RPMI 1640
HEPES modification (Sigma-Aldrich, St. Louis, MO) containing
10% fetal bovine serum (FBS, Invitrogen), 1% non-essential amino
acids (Invitrogen), 100 U/mL penicillin, 0.1 mg/mL streptomy-
cin, 1 mM L-glutamine, 1 mM sodium pyruvate, and 0.1% b-
mercaptoethanol.
Hemagglutination inhibition assay
Antibodies against the specific influenza strains contained in the
vaccine formulation were tested by hemagglutination inhibition
(HI) assay. Briefly, serum was drawn from 5 cc of whole clotted
blood that had been centrifuged in an untreated vacutainer tube
and was frozen until use. Influenza-specific antibodies were
detected in serum by HI assay as previously described [27].
Assessment of T cell responses to live influenza virus
challenge
PBMC were resuspended in complete medium to 1610
7 cells/
mL and plated at 0.1 mL/well in a microtiter round-bottom plate.
Cell suspensions were infected with 5 hemagglutination units
(HAU)/well of influenza virus or 2000 PFU/well of LCMV
Armstrong strain and maintained at 37uC, 5% CO2 for 18 hours.
Brefeldin A (BD Biosciences) was added to all wells at a final
concentration of 1.5 mL/mL for intracellular cytokine accumula-
tion during the last 6 hours of stimulation.
Influenza-specific tetramer staining in HLA-A2 donors
PBMC were thawed in complete medium and resuspended to
4610
6 cells/well in a round-bottom microtiter plate. Biotinylated
MHC I/peptide monomers (obtained from the University of
Montreal immunophenotyping laboratory) were conjugated with
extravidin-PE (Sigma-Aldrich) to create tetramers. The tetramer
used for HLA-A2 donors was M1 (GILGFVFTL). Cells were
stained with surface markers and tetramer concurrently for one
hour at 4uC in PBS with 3% FCS, 1% sodium azide.
Flow cytometry
The following anti-human mAbs were used: CD27, CD28,
CD8, CD3, IFNc, CD45RA, TNFa (eBioscience); CD57 (BD
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13F12F2). For intracellular cytokine detection, cells were first
stained for surface markers, fixed and permeabilized with Cytofix/
Cytoperm (BD Biosciences), then stained for intracellular markers
for 30 minutes at 4uC. Fluorescence intensity was measured using
an LSR II (BD Biosciences). Approximately 4610
6 total PBMC
were used for the viral stimulation assay per condition. The entire
sample was collected during flow cytometry, resulting in a typical
range of 3610
4 to 1.3610
5 CD8 T cell events collected per
condition, with fewer CD8 T cells observed in samples isolated
from older donors. Direct ex vivo tetramer staining produced
approximately 1610
5 to 5610
5 CD8 T cell events per sample.
Fluourescence minus one (FMO) controls were used to determine
background levels of staining. For tetramer staining, gates were
placed based on both FMO and analysis of contours from the total
CD8 T cell population. If the tetramer gate was placed only on the
tetramer bright, rather than the total tetramer population (relative
to FMO), the phenotypic trends observed were identical, but due
to the limited number of events, statistical significance was weaker.
Data were analyzed using FlowJo software (Tree Star) and SPICE
version 5 [29] (available from the National Institute of Allergy and
Infectious Diseases).
Statistical Analysis
When comparing only two groups, an unpaired, two-tailed t-test
was performed. For comparing more than two groups, a one-way
analysis of variance (ANOVA) followed by a Tukey test was used.
Correlations between two variables were assessed for significance
by Pearson correlation. A 95% confidence interval was selected for
each test.
Results
The functional recall T cell response to influenza differs in
frequency between the old and the young
The matrix and nucleoprotein epitopes in influenza A viruses
have changed little between 1934 and the present day [21]. To
avoid confounding issues from responses to recent seasonal-specific
responses and to capture as much of the cross-reactive conserved
T cell response as possible, we used the H1N1 strain from 1934,
A/PR8, for ex vivo stimulation since it would allow us to assess
recall CD8 T cell responses to influenza virus independently of
HLA type over a wide range of ages in the study population. As
IFNc is the predominant cytokine produced by CD8 T cells
responding to viruses, we used IFNc positive cells to identify
influenza reactive T cells. Forty-four older donors (28 donors aged
65–74, 16 donors aged 75+) and 12 young controls (aged 20–40)
were recruited prior to the 2008–2009 influenza season and
vaccinated with seasonal influenza vaccine as described in the
methods.
In pilot studies we found that maximal IFNc production was
observed between 12 and 18 hours of stimulation with 5 HAU of
PR8 (data not shown). Fig. 1A shows representative gating for a
single donor stimulated with influenza virus for 18h. After gating
on T cell populations based on CD3 and CD8 staining, phenotype
and functional marker gates were determined based on FMO
controls. T cells which produced IFNc above the FMO
background were considered to be influenza responsive. IFNc
values reported for this study are the difference of the IFNc
percentage in the PR8-stimulated culture and unstimulated total
PBMC control. Responses to A/PR8 varied between donors, with
responses as high as 0.93% in the CD8 T cell compartment
(representative donors shown in Fig. 1B). To control for non-
specific responses of the PBMC to a viral infection, we also
stimulated the human PBMC with a rodent RNA virus, LCMV
Armstrong, as a control, as most humans would not be expected to
have been exposed to this virus. Indeed for those donors tested,
responses to LCMV were similar to unstimulated control (Fig. 1C);
therefore for the remainder of the study we used the unstimulated
condition to measure background IFNc production. Although the
frequency and number of IFNc
+ events was quite small,
particularly in older donors, by examining a large cohort of
donors, we could identify a consistent phenotypic pattern in young
and older PBMC samples.
Having optimized the ex vivo restimulation assay, we compared
the frequency of influenza reactive T cells in PBMC from older
and younger donors taken prior to vaccination. By gating on the
CD8
+ or CD8
2 CD3 populations, we compared both CD8 and
CD4 T cells (Fig. 2A). In general, donors 65 and older showed a
reduced frequency of influenza reactive T cells following ex vivo
stimulation with influenza virus (P=0.054 for CD8 T cells and
P=0.005 in the CD4 populations).
Influenza reactive T cells from the older donors are of a
late effector phenotype
Memory T cell subsets can be categorized based on their
expression of specific CD45 isoforms [30–32]. Naı ¨ve T cells
express the CD45RA isoform, which is then replaced with
CD45RO upon conversion to the memory population. However,
late effector T cells can re-express CD45RA in the absence of the
RO isoform [30–34].
It has been previously demonstrated that stimulation of
influenza-specific T cells does not result in detectable cell division
before day 4 in culture [35]. As PBMC were stimulated for a
maximum of 18 hours, influenza-specific IFNc positive cells that
we detect cannot come from a naı ¨ve population. Thus CD45RA
staining was used to distinguish memory T cells from late effector
cells. In young donors, the majority of IFNc
+ CD8 and CD4 T
cells are of the memory CD45RA
2 phenotype (Fig. 2B). However,
in the older group, the frequency of the CD45RA
2 memory
population of T cells is significantly reduced, resulting in an
enrichment of the CD45RA
+ population. Based on the proportion
of CD45RA
+ influenza-responsive T cells, it appears that late
effector T cells could not compensate in the functional T cell
repertoire for the loss of the memory subset in older donors.
Another marker of differentiation is the presence or absence of
the costimulatory receptors CD28 and CD27. CD27 and CD28
are highly expressed on naı ¨ve T cells, with some expression
maintained or re-activated upon stimulation in early memory T
cell stages. However, their expression can be attenuated by the late
stage differentiation of human CD8 T cells depending on their
specificity [30–34,36–39]. Moreover, CD27 has been shown to be
critical for maintaining telomerase activity in human CD28
2
memory CD8 T cells [40]. Most influenza reactive T cells from the
young donors express both CD28 and CD27 on their surface
(Fig. 2C). In contrast, CD8 T cells from the older population
showed a dramatic loss of the CD28 CD27 double positive
population and a gain of CD28 CD27 double negative CD8 T
cells (Fig. 2C).
Granzyme B expression was also measured in the CD8 T cell
populations. Granzyme B is expressed in memory CD8 T cells and
is important for mediating the killing of virus-infected cells [41,42].
We found that granzyme B was expressed in a greater proportion
of the influenza reactive IFNc positive CD8 T cells from older
donors, however, as has been shown by others [26], granzyme B is
also overexpressed in the total CD8 T cell population of 65+
donors. Overall, the frequency of CD8 T cells which were dual
positive for granzyme B and IFNc out of the total CD8 T cell
Influenza-Specific CD8 T Cells in Older Adults
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(Fig. 2D).
Taken together, the loss of influenza-specific CD45RO memory
T cells and the enrichment of CD27
2CD28
2 CD8 influenza
specific T cells suggests that the less differentiated memory
population is decreased in the older population, resulting in an
increased proportion of the late effector subset.
HLA-A2 influenza M1 tetramer positive memory T cells
show evidence of immune dysfunction and senescence
The finding that influenza-specific T cells in 65+ donors show
signs of terminal differentiation was based on their functional
ability to produce IFNc upon restimulation. Therefore, we sought
to analyze the phenotype of the influenza-specific resting memory
T cell pool independently of restimulation. As about half the
donors in the cohort were HLA-A2 positive, we used an HLA-A2
tetramer containing the immunodominant influenza M158–66
epitope to characterize the influenza-specific memory population
directly ex vivo (Fig. 3). The tetramer positive population
identified based on FMO controls showed a weakly staining
population as well as a tetramer bright population. Control
experiments (Fig. 3A right) with HLA-A2-negative donors showed
that this tetramer population is specific to the HLA-A2 positive
donors. It is possible that the tetramer dim population represents T
cells with a lower level of TCR. Although the proportion of
tetramer positive CD8 T cells specific for influenza M1 varied
between donors, in contrast to the functional results, the frequency
of these CD8 T cells was largely unaffected by age (Fig. 3A left).
The cell surface proteins KLRG1 and CD57 have previously
been reported to be co-expressed on replicatively senescent
memory and effector T cells and are often present on T cells
specific for chronic latent infections such as human cytomegalo-
virus [13,14,16]. We thus aimed to ascertain whether these
senescence markers could also be co-expressed on memory CD8 T
cells generated from an acute influenza infection. Indeed, almost
half of all tetramer positive influenza-specific CD8 T cells from
older HLA-A2 donors exhibited dual expression of KLRG1 and
CD57 immediately ex vivo (Fig. 3B). This was also observed when
we gated only on the tetramer bright population (data not shown).
Young donors had significantly larger proportions of non-
senescent KLRG1
2CD57
2 CD8 T cells, while KLRG1
+CD57
+
cells were very rare in this age group.
Figure 1. Flow cytometry gating strategy and specificity controls for detection of CD8
+ and CD8
2 T cells producing IFNc in
response to live influenza virus challenge. Total PBMC from under 40 years old donors and 65+ donors were stimulated with influenza A/PR8
for 18h as described in the methods, then stained for intracellular IFNc and analyzed by flow cytometry. Influenza-responsive T cells were considered
to be those that produced IFNc after 18 hours of stimulation. Gates were drawn based on FMO controls. (A) Representative gating of flow cytometry
data collected from total PBMC of an older donor stimulated with PR8. (B) CD8 T cells from two donors representing strong (top panels) and weak
(bottom panels) IFNc responses to PR8 stimulation. (C) CD8 T cell IFNc responses to influenza virus stimulation (left), an irrelevant control virus,
lymphocytic choriomeningitis virus Armstrong strain (middle) or without stimulation (right) for 18 hours.
doi:10.1371/journal.pone.0023698.g001
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senescent CD8 T cells, we analyzed the correlation between the
proportion of the tetramer
+ cells which were dual positive for
senescence markers with the donor’s ability to produce IFNc in
response to 18h PR8 virus stimulation (Fig. 3C). A negative
correlation was found in older HLA-A2 donors between the
Figure 2. Older donors have fewer influenza-responsive T cells prior to vaccination and a higher proportion of these T cells are of a
late effector phenotype than those in younger donors. PR8-stimulated T cells were phenotyped for memory and effector T cell markers
CD45RA, CD28, and CD27 in young, under 40 and older, 65+ donors. CD8 T cells were also examined for granzyme B expression after stimulation
(flow cytometry gating as in Figure 1). (A) Proportions of influenza functionally responsive CD8 (left) and CD4 (right) T cells out of total CD8 and CD4
pools. (B) Division of influenza responsive CD8 and CD4 T cells into CD45RA
2 memory and CD45RA
+ late effector cell subsets. (C) Costimulatory
molecule expression profiles in young and older donors in influenza responsive CD8 and CD4 T cells. (D) Granzyme B expression within the influenza
responsive IFNc
+ CD8 T cell subset (left) and overall proportions of granzyme B
+IFNc
+ CD8 T cells out of the total CD8 T cell population (right).
doi:10.1371/journal.pone.0023698.g002
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+CD57
+ influenza-specific T cells and the
ability to functionally respond to influenza virus in vitro. No such
correlation was found in the young controls, for which the mean
percentage of CD8 T cells with co-expression of senescence
markers was less than 15%.
The inhibitory receptors Programmed Death 1 (PD-1) and T
cell immunoglobulin domain and mucin domain 3 (Tim-3) are
over-expressed in chronic infections including LCMV in mouse
[43,44] and HIV [45–49] and HCV [50] in humans. We therefore
analyzed whether these same markers are expressed on influenza-
specific CD8 T cells as a consequence of normal aging. Tetramer
positive cells were negative for Tim-3 and expressed only slightly
elevated levels of PD-1 that, although higher than FMO controls,
were indistinguishable from background levels detected on total
CD8 T cells (Fig. S1). Thus the KLRG1
+CD57
+ influenza-
specific T cells, while resembling senescent cells specific for the
persistent pathogen CMV, are distinct from the exhausted T cells
observed in chronic HIV or HCV infection.
Taken together, the results show that although age does not
seem to affect the proportion of influenza M1-specific CD8 T cells
within the total CD8 T cell pool, these cells express markers
associated with immune senescence, and this correlates with the
lower frequency of IFNc production in response to live influenza
virus in the older group.
CD4 and CD8 T cell responses to live influenza virus pre-
vaccination predict the ability to generate robust
antibody responses upon vaccination with TIV
It is well documented that the ability to generate antibodies
upon vaccination is diminished with age [51–53]. Analysis of
antibody responses following immunization of this cohort
confirmed this finding, with considerably lower peak antibody
titers produced against the seasonal H1N1 strain, A/Brisbane/59/
2007, which was contained in the vaccine (Fig. 4A). Although
antibody responses were weaker in the 65+ donors overall, a
heterogeneity in peak titers was observed.
To determine whether vaccination altered the cross-reactive
functional T cell response, we examined the ability of PBMC to
respond to PR8 virus ex vivo in the cohort post-vaccination and
compared the T cell response to the pre-vaccination analysis. We
observed no major changes in the proportions of functional
influenza-specific CD8 and CD4 T cell responses of young or
older donors post-vaccination (Fig. 4B), indicating that there is
little T cell response to this vaccine.
Figure 3. Influenza-specific T cells from older donors have a late effector phenotype and express markers associated with
replicative senescence. Total unfractionated PBMC from HLA-A2 donors were stained directly ex vivo for the M1-specific T cell receptor by
tetramer and for the markers KLRG1 and CD57. (A) Tetramer positive CD8 T cells from HLA-A2 positive young and older adults. Representative
staining is shown for KLRG1 and CD57 in the tetramer positive subset overlaid on the total CD8 T cell population in a young and 65+ donor. The
rightmost panels show A2/M1 tetramer staining on an A2 and a non-A2 donor, to confirm tetramer staining specificity. This control was repeated
with 3 A2 positive and 3 A2 negative donors with similar results. (B) KLRG1 and CD57 phenotypes in the tetramer positive influenza-specific CD8 T cell
population from under 40 and 65+ HLA-A2 positive donors. (C) Comparison of IFNc expression in CD8 T cells stimulated for 18 hours with PR8 and
the relative proportion of tetramer positive CD8 T cells which co-express KLRG1 and CD57 directly ex vivo on a per-donor basis in HLA-A2 positive
older (65+) donors.
doi:10.1371/journal.pone.0023698.g003
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were relatively unaffected by the TIV, the analysis of the
phenotype and quantity of the T cell response prior to vaccination
offered the possibility of asking whether the pre-vaccination
influenza-specific T cell population can predict the response to
vaccination (as measured by antibody titers from the hemagglu-
tination inhibition assay). Indeed, the frequency of functional
influenza-specific CD4 and CD8 T cell responses in the older
group pre-vaccination correlated with the subsequent antibody
response post-vaccination (Fig. 4C), with the caveat that the
correlation is lost between CD8 T cell responses and antibody
responses if the two highest IFNc responders are removed.
Although there was a trend in young donors toward a
proportionally more functional population compared to the older
group, this finding was not statistically significant (Fig. 5A). We
found however, that for the younger group, an enhanced pre-
vaccination population of tetramer
+ CD8 T cells strongly
correlated with successful antibody production upon vaccination
with TIV (Fig. 5B). Surprisingly, an inverse correlation was found
in the 65+ group, with poor antibody responses in donors who had
Figure 4. An effective T cell response to whole influenza stimulation prevaccination predicts higher peak antibody titers post-
vaccination. Antibody production pre-vaccination and four, ten, and twenty weeks post-vaccination with TIV was measured by hemagglutinin
inhibition assay. Titers against A/Brisbane/59/2007, an H1N1 strain contained in the seasonal vaccine, are shown. T cell responses post-vaccination
were measured as described in Figure 1 for pre-vaccination samples. (A) Antibody responses in serum from young (N, solid line) and 65+ (#, dashed
line) donors against A/Brisbane/59/2007 (H1N1) before and after vaccination with TIV. (B) CD8 (left) and CD4 (right) T cell responses to PR8 before and
after vaccination as measured by IFNc cytokine production. (C) Correlation between IFNc
+ CD8 (left) and CD4 (right) T cells present at pre-vaccination
and peak antibody titers post-vaccination with TIV in older donors.
doi:10.1371/journal.pone.0023698.g004
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vaccination (Fig. 5C). However, upon further examination of older
donors, we observed that many of the tetramer
+ CD8 T cells were
KLRG1
+CD57
+, and that an increased frequency of these
KLRG1
+CD57
+ influenza-specific cells correlated with a poor
vaccination outcome for H1N1 (Fig. 5D). No such correlation was
found when the KLRG1
+CD57
+ population from the total CD8 T
cell population was compared with peak antibody titers post-
vaccination, arguing that it is the influenza-specific T cell memory
phenotype that is predictive of vaccine outcome (Fig. 5E).
Functionally competent memory CD8 T cells from 2008
samples cross-react with A/California 2009 influenza
We have shown that older donors are more likely to have a late
effector population of influenza-responsive T cells, and that many
of the CD8 T cells specific for influenza show a terminally
differentiated phenotype. Nevertheless, at least 30% of the
influenza M1 tetramer positive cells in the older group remained
KLRG1 CD57 double negative, and should maintain the ability to
respond to infection. Moreover, functional (IFNc secreting) CD8
T cells could be identified after restimulation of PBMC from the
older donors and about 35% of these were of the less differentiated
CD28
+CD27
+ phenotype. Therefore, these cells have the potential
to protect against subsequent infection.
CD8 T cells tend to be highly cross-reactive between strains and
may limit disease severity in cases where neutralizing antibodies
are absent [23,54]. Ten pre-pandemic PBMC samples from the
cohort, representing all age groups, were tested for T cell responses
to the recent pandemic influenza, A/California/7/2009-like
strain, to determine whether a functional cross-reactive memory
CD8 T cell response could be elicited against a novel strain.
Indeed, we found that regardless of age, for all donors tested, their
CD8 T cell response to A/California stimulation measured as the
frequency of IFNc producing T cells was similar in magnitude as
their response to A/PR8 stimulation (Fig. 6A,B). Phenotypes of
functional ability were further examined in the CD8 T cell IFNc
+
subsets activated from the two strains (Fig. 6C). In both PR8 and
A/California stimulations, about 1/3 of the influenza responsive
CD8 T cells were also granzyme B
+. Smaller proportions of IFNc
+
CD8 T cells were capable of co-producing TNFa, and the
proportions of multifunctional T cells were similar after activation
with either virus. Only a very small fraction of CD8 T cells were
Figure 5. The functional influenza repertoire diminishes with age compared to the pool of influenza-specific CD8 T cells and the
proportion of KLRG1
hi CD57
hi influenza-specific T cell pre-vaccination inversely correlates with vaccine responsiveness. IFNc
positive populations were identified by influenza virus challenge as described in the methods. Influenza-specific CD8 T cell populations were
identified by tetramer staining direct ex vivo for HLA-A2 donors. Comparisons between IFNc and tetramer were made on a per-donor basis from pre-
vaccination PBMC samples of young and older donors. (A) Ratio of IFNc positive and tetramer positive CD8 T cells at pre-vaccination. (B) Comparison
of peak antibody titers against seasonal H1N1 post-vaccination and total influenza-specific CD8 T cells out of total CD8 T cells present at pre-
vaccination in young donors. (C) Correlation between peak H1N1 antibody titers induced from TIV vaccination and pre-existing tetramer
+ CD8 T cells
specific for influenza in older HLA-A2 donors. (D) The proportion of pre-existing CD8 T cells which were triple positive for KLRG1, CD57, and tetramer
staining in 65+ donors inversely correlates with their peak H1N1 antibody titer production post-vaccination with TIV. (E) Lack of correlation between
peak H1N1 antibody titers and frequency of KLRG1
+CD57
+ CD8 T cells in the total CD8 population.
doi:10.1371/journal.pone.0023698.g005
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18h of stimulation. Therefore, although a significant proportion of
T cells from older donors express markers that indicate an
advanced state of differentiation sometimes associated with
immune senescence [38,55], there are still sufficient functional
influenza-specific CD8 T cells to mount a cross-reactive immune
response to the recent H1N1 strain. As suggested by others [56],
such cross-reactive T cell populations may have contributed to the
diminished disease severity observed during the 2009 influenza
pandemic.
Discussion
T cells in humans are well known to accumulate phenotypic and
functional changes with age. For example, CD8 T cells in older
humans are more likely to lack the costimulatory molecules CD28
and CD27 and express CD45RA as well as KRLG1 and CD57
[14,30–34,36–39,57]. This phenotype has been attributed to the
oligoclonal expansion of T cells that were stimulated repetitively
over a lifetime to control persistently infecting pathogens such as
CMV. Less clear however, is the effect of aging on the phenotype
of T cells specific for an acutely infecting pathogen such as
influenza virus. Here we have demonstrated that an acute
infection can similarly result in the accumulation of late effector
CD8 T cells that show markers that have been previously
associated with immune senescence seen in late chronic infections
such as with CMV.
The CD45RA marker is normally expressed on naı ¨ve T cells as
well as late effectors. We detected CD45RA on IFNc-producing
influenza-specific T cells after only 18h of stimulation, a timepoint
which is too short for the expansion of influenza-specific T cells
from naı ¨ve precursors. Therefore, the CD45RA marker can be
used to identify late effector cells. We found a higher proportion of
the influenza responsive CD8 and CD4 T cells were of this late
Figure 6. Older donors can mount a T cell response against novel influenza strains despite expression of a significant fraction of
influenza-specific T cells that express markers of late differentiation and senescence. Ten donors (2 under 40, 8 donors 65+) from the
cohort were selected for in vitro stimulation with A/California/7/2009-like influenza virus. Donor PBMC from either the pre-vaccination or 4 week
post-vaccination timepoints were stimulated for 18 hours with 5 HAU of either A/California or PR8, 2000 PFU of LCMV Armstrong, or were left
unstimulated, then stained for IFNc to detect influenza-responsive T cells. Other effector markers, TNFa and granzyme B, were also measured to
assess function. (A) Representative strong (top) and weak (bottom) donor CD8 T cell responses against A/California. (B) Comparison of A/California and
PR8 CD8 T cell responses on a per-donor basis as measured by IFNc staining in select young (filled symbols) and 65+ (open symbols) donors. (C)
Proportion of IFNc positive CD8 T cells with multifunctional effector potential in A/California and PR8-responsive T cells.
doi:10.1371/journal.pone.0023698.g006
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+ phenotype, and that CD8 but not CD4 T cells
had also significantly lost expression of costimulatory molecules
CD28 and CD27. Similar findings have been made for CMV-
specific T cells [34,58], and the presence of CD45RA
+ cells has
also been noted in influenza-stimulated PBMC from older subjects
[59]. The overall frequency of CD45RA
+ influenza-specific CD8
T cells out of total CD8 T cells was similar in the old and the
young; rather it was the proportion of CD45RA
+ influenza-specific
T cells out of the influenza-specific CD8 T cells that was higher,
arguing that it was a loss of the less differentiated CD45RO cells
that led to the higher proportion of CD45RA
+ influenza-specific T
cells in the older group.
By using A2/M1 tetramers to identify influenza specific T cells
directly ex vivo we also observed that a higher proportion of
influenza-specific CD8 T cells from older donors were double
positive for KLRG1 and CD57, inhibitory receptors implicated in
proliferative senescence [14,16,60]. CD27 and CD28 are also
thought to be necessary for maintenance of telomerase function
and the continued ability to proliferate upon stimulation
[40,61,62]. T cell memory to influenza in the older group contains
a significant proportion of cells expressing markers that have been
attributed to immune senescence.
There are at least two possible explanations for why older
donors’ influenza-specific T cells would be enriched in more
differentiated effector cells. They may have lost their RO memory
T cells due to repetitive stimulation or these cells may be absent
due to failure to receive sufficient survival signals for their
maintenance over time, or a combination of the two. It has been
previously observed that the influenza protein composition of the
TIV varies depending on the manufacturer [63]. Since the Sanofi
formulation of the seasonal TIV contains minimal internal viral
protein compared to the levels of hemagglutinin and is optimized
for its induction of antibody rather than T cell responses, older
individuals’ T cells may not have been sufficiently boosted in
recent years. Indeed, as has been reported by others [64,65], we
saw little or no increase in the cross-reactive T cell response upon
vaccination in the old or young. In Canada, seniors (65+) have
been recommended to receive influenza vaccination since 1999
[66] and thus may have been repeatedly vaccinated and lost the
opportunity for a natural infection to boost the T cell response. In
a mouse model of viral infection, it was shown that secondary
restimulation is required for high avidity antibodies and enhanced
T cell functionality in old but not adult aged mice [67]. Whether
the addition of T cell epitopes and appropriate adjuvants to the
influenza vaccine administered earlier in life could improve the
lifespan of functional influenza-specific T cells into old age remains
to be determined.
A live attenuated influenza vaccine (LAIV) has been approved
for people aged 5–49 in the United States and was recently also
approved for use in Canada. Although live vaccines are expected
to be more efficient in inducing cross-protective T cell responses,
no protective benefit was shown for LAIV-vaccinated individuals
aged 50 and over [68,69]. It may be that LAIV may not provide
additional protection to elderly individuals due to pre-existing IgA
antibodies in the respiratory tract. It is also possible that the viral
titers present in LAIV are not sufficiently high to robustly
restimulate T cell memory. A recent study showed that in a mouse
model, the inclusion of the CD8 T cell costimulatory ligand, 4-
1BBL, in a single dose replication defective adenovirus vaccine
containing influenza NP, resulted in sustained functional CD8 T
cell responses in the lungs out to 6 months post-vaccination and
prolonged protection against influenza induced disease [70].
Vaccines that incorporate both CD8 T cell epitopes and adjuvants
that prolong CD8 T cell memory would therefore be of interest to
improve influenza vaccines.
A second scenario that might explain the loss of functional
memory T cells in older adults is that the healthy older donors
may have encountered multiple influenza infections in their
lifetime and this repeated reactivation, as in latent persistent
infections, may have driven CD8 and CD4 T cells towards
terminal differentiation and senescence. In support of this, Bucks
et al. [71] showed that repetitive infection of mice with influenza
virus can lead to functional exhaustion as measured by loss of
IFNc producing cells and upregulation of TNF receptor apoptosis-
inducing ligand (TRAIL), without the upregulation of PD-1. This
is similar to the phenotype we observe in influenza-specific T cells
from older humans, which also resemble T cells specific for a
persistent latent infection (CMV). In contrast, the cells in both the
mouse influenza study and the present report are distinct from the
PD-1
hi phenotype observed with viruses that maintain a
chronically higher viral load, such as seen in HIV [43,46–49] or
HCV infection [50]. Consistent with these findings, a recent study
demonstrated that PD-1 expression in healthy individuals does not
correlate with the exhausted phenotype found during chronic
infection, but rather with the effector memory population of CD8
T cells [72].
With the available data we cannot formally conclude whether
repeat exposure to influenza virus and/or failure to boost memory
T cells leads to this late differentiated phenotype. However, the
ability to predict the response to influenza vaccination by
examining only the influenza-specific population of
KLRG1
+CD57
+ CD8 T cells but not the total CD8 T cell pool
leads us to suggest that these observations may reflect a specific
effect of multiple rounds of exposure to influenza.
Despite the late differentiation state in healthy older adults,
cross-reactive T cell populations capable of responding to a new
influenza virus, A/California/7/2009, persisted. As many indi-
viduals in the population may not possess sufficiently protective
levels of neutralizing antibody against A/California, cross-reactive
CD8 T cells could have ameliorated disease severity in these
individuals. Evidence of cross-reactivity between influenza-respon-
sive memory CD8 T cells was found through in vitro challenge
with A/California, a virus that, at the time of sample collection (in
the fall of 2008), we presume none of the donors had been
exposed. There have also been multiple studies which have
identified pre-existing cross-reactive neutralizing antibodies to A/
California in older populations, which when combined with CD8
T cell responses, may have been responsible for the lack of
infection seen in the older population during the 2009 pandemic
[73]. However, similar to seasonal influenza, those older people
who were infected with influenza tended to show severe outcomes
[74]. As has been suggested by others [56], these cases of older
individuals who did acquire illness from A/California may have
been those with the most functionally senescent T cell memory to
influenza virus.




CD8 T cells specific for EBV [75] and CMV [14,16,76] have been
previously noted in aging and indeed the presence of oligoclonal
expansions of CMV-specific T cells have been cited as a way of
determining the functional immune age of the immune system
[4,75]. However, it is difficult to assess whether the CMV infection
actually contributes to the aging of the immune system or simply
that as the immune system ages and T cells become less effective at
controlling chronic infections, viral reactivation becomes more
frequent, leading to further clonal expansion of the CMV-reactive
T cells and their terminal differentiation. In contrast, as influenza
is an acute infection without the issue of reactivation within the
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population may represent a more useful prognostic indicator of a
healthy immune system independent of the effects of chronic
infection and inflammation on aging and mortality, with the
caveat that the state of these cells may also reflect the history of
influenza exposure.
There is currently much interest in understanding the correlates
of a healthy immune system. As pointed out by others [10,77], to
date we have only minimal information about what features of the
immune system should be measured in order to evaluate this point.
In this study, the vaccination of a healthy older cohort resulted in a
range of antibody responses, thereby offering the opportunity to
compare pre-vaccination influenza-specific T cell frequency and
phenotype with the response to the vaccine. In the younger group,
the frequency of HLA-A2/M1 tetramer positive T cells pre-
vaccination correlated well with the subsequent H1-specific
antibody response to the seasonal H1N1 contained in the vaccine.
Paradoxically, the older group actually showed a decreased
response the higher the pre-vaccination tetramer
+ T cell
frequency. However, further analysis indicated that this negative
correlation was largely due to the presence of a high proportion of
‘‘senescent’’ phenotype KLRG1
+CD57
+ cells that were mostly
absent in younger donors. CD8 T cell responses are generally
thought not to contribute to antibody responses and yet the data
show a correlation between the state of the cross-reactive CD8 T
cell response (to internal viral proteins) pre-vaccination and the
subsequent antibody response to the 2007 H1. Thus by comparing
the influenza-specific CD8 T cell phenotype pre-vaccination with
the antibody response to the vaccine, we may instead be getting a
read-out of the general robustness of the immune system. Indeed,
others have shown that expansions of the total CD8
+CD28
2 T cell
population in older individuals correlates with a poor vaccination
outcome [78,79]. On the other hand, we cannot rule out that these
findings reflect the specific exposure of individuals to multiple
influenza viruses over their lifespan, leading to a desensitization of
both antibody and T cell responses to influenza.
Several recent studies, using either granzyme or cytokine release
from total PBMC upon restimulation with influenza virus, have
suggested that older adults have less functional responses to
influenza virus than younger adults and that cell-mediated
immunity is a better predictor of vaccine responsiveness or
protection from influenza virus than are antibody responses
[25,26,59]. However, we find that if anything the older donors
have generally higher levels of granzyme B than the younger
donors, consistent with their accumulation of more late effector
cells. Although the previous studies did not specifically gate on
influenza-specific T cells and therefore may also have included
NK cell responses, the present study agrees with previous findings
suggesting that cell-mediated immunity is a better predictor of
vaccine responses than pre-existing antibodies. We found that
influenza-specific IFNc production by CD4 and perhaps CD8 T
cells or the absence of the KLRG1
+CD57
+ influenza-specific
tetramer positive population each independently predict influenza
antibody responses upon vaccination. Vaccine responsiveness may
be a reflection of a healthy older immune system [25,59].
In sum, we have shown that in older persons the memory T cells
specific for an acutely infecting virus, influenza, exhibit a loss of
the less differentiated memory population and enrichment of
memory T cells exhibiting a late differentiation phenotype that has
been previously associated with immune senescence. It remains to
be determined whether these late effectors are indeed senescent or
could be rescued by appropriate boosting. We further show that
the influenza vaccine responsiveness of older adults is predicted by
the status of their influenza-specific memory CD8 T cells.
Supporting Information
Figure S1 PD-1 expression is elevated in both influenza-
specific and total CD8 T cells from older individuals. PD-
1 levels were measured by flow cytometry direct ex vivo in
conjunction with tetramer staining for HLA–A2 positive young
and older donors. Left: Median fluorescence intensity (MFI) of PD-
1 in influenza M1-specific CD8 T cells. Right: Representative PD-1
expression in tetramer
+ and total CD8 T cells compared to FMO
control (shaded) in under 40 and 65+ donors.
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